Company / Capital Returned to Shareholders per Share
Avanos Medical, Inc. Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.07
FY2025
5-year range
$0.07 / $0.94
FY2021-FY2025
Trend
-74.1%
vs FY2024
Sector context
#87 of 103
Health Care
What the data says
Avanos Medical, Inc.'s capital returned to shareholders per share of $0.07 is lower than 84% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders per Share has declined for 3 consecutive years, from $0.94 in FY2022 to $0.07 in FY2025.
Based on SEC 10-K filings.
0.07 in FY2025 with a 5-year CAGR of +30.7%.
Declined from $0.41 to $0.07 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -57.6%
- 5-Year CAGR
- +30.7%
- 10-Year CAGR
- -
Sector benchmark
-98.6% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s capital returned to shareholders per share has declined for 3 consecutive years.
- In FY2025, capital returned to shareholders per share decreased 74.1% year-over-year.
- Ranks #87 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | -74.1% |
| FY2024 | $0.28 | -32.5% |
| FY2023 | $0.41 | -56.5% |
| FY2022 | $0.94 | +293.3% |
| FY2021 | $0.24 | +1172.9% |
| FY2020 | $0.02 | -75.2% |
| FY2019 | $0.08 | +295.6% |
| FY2018 | $0.02 | -64.2% |
| FY2017 | $0.05 | +177.4% |
| FY2016 | $0.02 | -10.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026